Skip to main content

4 April 2026

Last updated: Saturday 4 April 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Value-based drug pricing coming soon in UK

Friday 5 April 2013

Interviewee/Contributor

Karen Fi nn

Organisation

MedNous

Organisations

Truffle Capital
Destiny Pharma Plc
Poolbeg Pharma Plc
Pharming Group NV
World Courier
AXA Framlington Biotech Fund
Shore Capital Ltd
Biocat
4SC AG
SparingVision SAS

Interviewees and Contributers

Shaun Grady
Todd McAllister
Kerry Cooper
Roger Pertwee
Will James
Ingmar Hoerr
Stéphane Degove
Jennifer Schneider
Bruce Booth
Claes Buxfeldt and Paula Salmikangas

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Poolbeg Pharma names drug developer to SAB

Saturday 14 March 2026

Commit Biologics names biotech entrepreneur as CEO

Saturday 14 March 2026

Orexo changes management in strategic shift

Saturday 14 March 2026

New CFO at Beacon Therapeutics

Saturday 14 March 2026

4basebio names new COO and CCO, strengthens commercial team

Saturday 14 March 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form